{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:24:55Z","timestamp":1756992295683,"version":"3.41.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Ther Perspect"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40267-016-0355-9","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T13:58:42Z","timestamp":1477490322000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-1421","authenticated-orcid":false,"given":"Cristiano","family":"Matos","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o","family":"Joaquim","sequence":"additional","affiliation":[]},{"given":"Tim\u00f3teo","family":"Pires","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"issue":"15","key":"355_CR1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200\u20135.","journal-title":"JAMA."},{"issue":"7456","key":"355_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15\u20139.","journal-title":"BMJ."},{"issue":"4","key":"355_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"MT Herdeiro","year":"2006","unstructured":"Herdeiro MT, Figueiras A, Pol\u00f3nia J, et al. Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting. Drug Saf. 2006;29(4):331\u201340.","journal-title":"Drug Saf."},{"issue":"2","key":"355_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pds.1263","volume":"16","author":"K Wester","year":"2007","unstructured":"Wester K, J\u00f6nsson A, Spigset O, et al. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden. Pharmacoepidemiol Drug Saf. 2007;16(2):173\u201380.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"355_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-200022020-00007","volume":"22","author":"H Dormann","year":"2000","unstructured":"Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation. Drug Saf. 2000;22(2):161\u20138.","journal-title":"Drug Saf."},{"issue":"1","key":"355_CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/11594320-000000000-00000","volume":"35","author":"F Hunsel van","year":"2012","unstructured":"van Hunsel F, H\u00e4rmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients. Drug Saf. 2012;35(1):45\u201360.","journal-title":"Drug Saf."},{"key":"355_CR7","first-page":"1","volume-title":"The importance of pharmacovigilance: safety monitoring of medicinal products","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva: World Health Organization; 2002. p. 1\u201348."},{"issue":"8","key":"355_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00228-008-0475-9","volume":"64","author":"L H\u00e4rmark","year":"2008","unstructured":"H\u00e4rmark L, Van Grootheest AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743\u201352.","journal-title":"Eur J Clin Pharmacol."},{"issue":"3","key":"355_CR9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40264-013-0021-2","volume":"36","author":"L Hazell","year":"2013","unstructured":"Hazell L, Cornelius V, Hannaford P, et al. How do patients contribute to signal detection? Drug Saf. 2013;36(3):199\u2013206.","journal-title":"Drug Saf."},{"issue":"2","key":"355_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40264-012-0014-6","volume":"36","author":"SN Pal","year":"2013","unstructured":"Pal SN, Duncombe C, Falzon D, et al. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36(2):75\u201381.","journal-title":"Drug Saf."},{"issue":"1","key":"355_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions. Drug Saf. 2009;32(1):19\u201331.","journal-title":"Drug Saf."},{"issue":"5","key":"355_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW. Under-reporting of adverse drug reactions. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf."},{"issue":"1","key":"355_CR13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.sapharm.2004.12.009","volume":"1","author":"AC Grootheest Van","year":"2005","unstructured":"Van Grootheest AC, De Jong-van den Berg LTW. The role of hospital and community pharmacists in pharmacovigilance. Res Soc Admin Pharm. 2005;1(1):126\u201333.","journal-title":"Res Soc Admin Pharm"},{"issue":"4","key":"355_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1211\/096176702776868460","volume":"10","author":"K Mes","year":"2002","unstructured":"Mes K, Berg LTW, Grootheest AC. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract. 2002;10(4):267\u201372.","journal-title":"Int J Pharm Pract."},{"issue":"15","key":"355_CR15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200\u20135.","journal-title":"JAMA."},{"issue":"7","key":"355_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pds.897","volume":"13","author":"K Grootheest van","year":"2004","unstructured":"van Grootheest K, Olsson S, Couper M, et al. Pharmacists\u2019 role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457\u201364.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"355_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pds.702","volume":"11","author":"AC Grootheest Van","year":"2002","unstructured":"Van Grootheest AC, Van Puijenbroek EP, de Jong-van den LTW. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(3):205\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"355_CR18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s11096-015-0166-4","volume":"37","author":"SAM Urru","year":"2015","unstructured":"Urru SAM, Pasina L, Minghetti P, et al. Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia. Int J Clin Pharm. 2015;37(6):1004\u20138.","journal-title":"Int J Clin Pharm."},{"issue":"4","key":"355_CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40264-013-0028-8","volume":"36","author":"R Leone","year":"2013","unstructured":"Leone R, Moretti U, D\u2019Incau P, et al. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Drug Saf. 2013;36(4):267\u201376.","journal-title":"Drug Saf."},{"issue":"5","key":"355_CR20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2125.1992.tb05646.x","volume":"34","author":"DN Bateman","year":"1992","unstructured":"Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992;34(5):421.","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"355_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2125.1995.tb04440.x","volume":"39","author":"KJ Belton","year":"1995","unstructured":"Belton KJ, Lewis SC, Payne S, et al. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223.","journal-title":"Br J Clin Pharmacol."},{"issue":"9","key":"355_CR22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00002018-200528090-00007","volume":"28","author":"MT Herdeiro","year":"2005","unstructured":"Herdeiro MT, Figueiras A, Polonia J, et al. Physicians\u2019 attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825\u201333.","journal-title":"Drug Saf."},{"issue":"5","key":"355_CR23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2125.1996.tb00040.x","volume":"41","author":"WH Inman","year":"1996","unstructured":"Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5):434.","journal-title":"Br J Clin Pharmacol."},{"issue":"2","key":"355_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00002018-200023020-00006","volume":"23","author":"D Sweis","year":"2000","unstructured":"Sweis D, Wong ICK. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165\u201372.","journal-title":"Drug Saf."},{"issue":"11","key":"355_CR25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/00002018-200730110-00006","volume":"30","author":"M Irujo","year":"2007","unstructured":"Irujo M, Beitia G, Bes-Rastrollo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073\u201382.","journal-title":"Drug Saf."},{"issue":"5","key":"355_CR26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11096-008-9209-4","volume":"30","author":"HZ Toklu","year":"2008","unstructured":"Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556\u201362.","journal-title":"Pharm World Sci."},{"issue":"6","key":"355_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002280050314","volume":"52","author":"KJ Belton","year":"1997","unstructured":"Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol. 1997;52(6):423\u20137.","journal-title":"Eur J Clin Pharmacol."},{"issue":"4","key":"355_CR28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2753.2001.00295.x","volume":"7","author":"A Figueiras","year":"2001","unstructured":"Figueiras A, Tato F, Fontai\u00f1as J, et al. Physicians\u2019 attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract. 2001;7(4):347\u201354.","journal-title":"J Eval Clin Pract."},{"issue":"4","key":"355_CR29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00002018-200831040-00007","volume":"31","author":"MT Herdeiro","year":"2008","unstructured":"Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31(4):335\u201344.","journal-title":"Drug Saf."},{"issue":"9","key":"355_CR30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s40267-015-0227-8","volume":"31","author":"M Duarte","year":"2015","unstructured":"Duarte M, Ferreira P, Soares M, et al. Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs Ther Perspect. 2015;31(9):316\u201322.","journal-title":"Drugs Ther Perspect."},{"key":"355_CR31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4172\/2329-6887.1000193","volume":"4","author":"HZ Toklu","year":"2016","unstructured":"Toklu HZ, Soyalan M, G\u00fcltekin O, et al. The knowledge and attitude of the healthcare professionals towards pharmacovigilance and adverse drug reaction reporting in Northern Cyprus. J Pharmacovigil. 2016;4:193.","journal-title":"J Pharmacovigil."},{"issue":"1","key":"355_CR32","first-page":"25","volume":"30","author":"N Sencan","year":"2010","unstructured":"Sencan N, Altinkaynak M, Ferah I, et al. The knowledge and attitudes of physicians and nurses towards adverse event reporting and the effect of pharmacovigilance training: a hospital experience. Hacettepe Univ J Fac Pharm. 2010;30(1):25\u201340.","journal-title":"Hacettepe Univ J Fac Pharm."},{"issue":"4","key":"355_CR33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pds.1298","volume":"16","author":"AG Granas","year":"2007","unstructured":"Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists\u2019 attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16(4):429\u201334.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"9","key":"355_CR34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jama.296.9.1086","volume":"296","author":"A Figueiras","year":"2006","unstructured":"Figueiras A, Herdeiro MT, Pol\u00f3nia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086\u201393.","journal-title":"JAMA."},{"issue":"4","key":"355_CR35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ijpp.12078","volume":"22","author":"J Marques","year":"2014","unstructured":"Marques J, Ribeiro-Vaz I, Pereira AC, et al. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Int J Pharm Pract. 2014;22(4):275\u201382.","journal-title":"Int J Pharm Pract."},{"issue":"2","key":"355_CR36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.20344\/amp.5717","volume":"28","author":"F Batel-Marques","year":"2015","unstructured":"Batel-Marques F, Mendes D, Alves C, et al. Pharmacovigilance in Portugal: regional center unit activity [in Portuguese]. Acta Med Port. 2015;28(2):222\u201332.","journal-title":"Acta Med Port."},{"key":"355_CR37","first-page":"14","volume":"72","author":"T Lundin","year":"2016","unstructured":"Lundin T. Postive trends for VigiBase: 12 million reports & counting. Uppsala Rep. 2016;72:14\u20135.","journal-title":"Uppsala Rep."},{"key":"355_CR38","unstructured":"INFARMED. National Pharmacovigilance System (SNF): notifications and RAM cases in 2015 [in Portuguese]. Lisbon: INFARMED; 2016."},{"issue":"2","key":"355_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11096-011-9605-z","volume":"34","author":"L Gokcekus","year":"2012","unstructured":"Gokcekus L, Toklu HZ, Demirdamar R, et al. Dispensing practice in the community pharmacies in the Turkish Republic of Northern Cyprus. Int J Clin Pharm. 2012;34(2):312\u201324.","journal-title":"Int J Clin Pharm."},{"key":"355_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.12991\/201014464","volume":"14","author":"HZ Toklu","year":"2010","unstructured":"Toklu HZ. The pharmacy practice of community pharmacists in Turkey. Marmara Pharm J. 2010;14:53\u201360.","journal-title":"Marmara Pharm J."},{"issue":"5","key":"355_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4212\/cjhp.v63i5.947","volume":"63","author":"R Johnston","year":"2010","unstructured":"Johnston R, Saulnier L, Gould O. Best possible medication history in the emergency department: comparing pharmacy technicians and pharmacists. Can J Hosp Pharm. 2010;63(5):359.","journal-title":"Can J Hosp Pharm."},{"issue":"10","key":"355_CR42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/02770903.2016.1180696","volume":"53","author":"JA Driesenaar","year":"2016","unstructured":"Driesenaar JA, De Smet P, van Hulten R, et al. Beliefs about inhaled corticosteroids: comparison of community pharmacists, pharmacy technicians and patients with asthma. J Asthma. 2016;53(10):1051\u20138.","journal-title":"J Asthma."}],"container-title":["Drugs & Therapy Perspectives"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40267-016-0355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40267-016-0355-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40267-016-0355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T21:26:39Z","timestamp":1749677199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40267-016-0355-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1007\/s40267-016-0355-9","relation":{},"ISSN":["1172-0360","1179-1977"],"issn-type":[{"type":"print","value":"1172-0360"},{"type":"electronic","value":"1179-1977"}],"subject":[],"published":{"date-parts":[[2016,10,26]]}}}